Nabi Biopharmaceuticals' Stockholders Approve NicVAX Option and License Agreement
02 mars 2010 12h00 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., March 2, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the "Company") announced that, at today's Special Meeting of Stockholders, its stockholders voted...
RiskMetrics Group and Glass Lewis & Co. Support Nabi Biopharmaceuticals' Proposed NicVAX Option and License Agreement
18 févr. 2010 13h15 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Feb. 18, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the "Company") announced today that RiskMetrics Group (ISS) and Glass Lewis & Co., two of the nation's...
Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement
09 févr. 2010 09h03 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Feb. 9, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the "Company") announced today that it has commenced mailing its definitive proxy statement to stockholders for...
Nabi Biopharmaceuticals Completes Another PentaStaph(TM) Milestone
08 févr. 2010 09h15 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Feb. 8, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that it has successfully completed the manufacture and transfer of specified materials associated...
Nabi Biopharmaceuticals to Receive $5 Million Milestone Payment From GlaxoSmithKline Biologicals
09 déc. 2009 09h25 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Dec. 9, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced the initiation of a Phase I/II clinical trial for two of the antigens in the PentaStaph(TM)...
Nabi Biopharmaceuticals to Hold Conference Call
16 nov. 2009 08h30 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 16, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will host a live webcast and conference call at 11:00 a.m. ET on Tuesday, November 17 to...
GSK and Nabi Announce Agreement for NicVAX(R), a Vaccine for Nicotine Addiction
16 nov. 2009 06h00 HE
|
Nabi Biopharmaceuticals
LONDON and ROCKVILLE, Md., Nov. 16, 2009 (GLOBE NEWSWIRE) -- GlaxoSmithKline Biologicals SA (GSK) and Nabi Biopharmaceuticals (Nabi) today announced an exclusive worldwide option and licensing...
Nabi Biopharmaceuticals Announces Third Quarter 2009 Financial Results
05 nov. 2009 16h05 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 5, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its third quarter financial results for the quarter ended September 26, 2009. The Company...
Nabi Biopharmaceuticals Completes Sale of PentaStaph(TM) to GlaxoSmithKline PLC
04 nov. 2009 09h15 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced that it has completed the sale of PentaStaph(TM) (Pentavalent S. aureus Vaccine) and related assets to...
Nabi Biopharmaceuticals Announces Withdrawal of Biotest's Indemnification Claim
03 nov. 2009 17h00 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 3, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Biotest Pharmaceuticals Corporation has withdrawn the claim and agreed to release the...